Fluselenamyl - Beta Amyloid PET Imaging for Alzheimer Disease
NCT05731440
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
18F-Fluselenamyl
Sponsor
Washington University School of Medicine